LEVIN ALAN G has filed 9 insider transactions across 1 company since February 2023.
Most recent transaction: a grant/award of 12500 shares of BIOCRYST PHARMACEUTICALS INC ($BCRX) on June 12, 2025.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 12, 2025 | BIOCRYST PHARMACEUTICALS INC | $BCRX | LEVIN ALAN G | Director | A | Common Stock | 12500 | $0.00 | 64,271.0000 | 206,696,000 | 24.14% | 0.01% |
| June 12, 2025 | BIOCRYST PHARMACEUTICALS INC | $BCRX | LEVIN ALAN G | Director | A | Automatic Stock Option Grant | 27181 | $0.00 | 27,181.0000 | 206,696,000 | 9999.99% | 0.01% |
| June 12, 2024 | BIOCRYST PHARMACEUTICALS INC | $BCRX | LEVIN ALAN G | Director | A | Common Stock | 6820 | $0.00 | 51,771.0000 | 192,198,000 | 15.17% | 0.00% |
| June 12, 2024 | BIOCRYST PHARMACEUTICALS INC | $BCRX | LEVIN ALAN G | Director | A | Automatic Stock Option Grant | 49933 | $0.00 | 49,933.0000 | 192,198,000 | 9999.99% | 0.03% |
| May 30, 2024 | BIOCRYST PHARMACEUTICALS INC | $BCRX | LEVIN ALAN G | Director | P | Common Stock | 7861 | $6.36 | 44,951.0000 | 192,198,000 | 21.19% | 0.00% |
| June 13, 2023 | BIOCRYST PHARMACEUTICALS INC | $BCRX | LEVIN ALAN G | Director | A | Common Stock | 16745 | $0.00 | 37,090.0000 | 185,908,000 | 82.31% | 0.01% |
| June 13, 2023 | BIOCRYST PHARMACEUTICALS INC | $BCRX | LEVIN ALAN G | Director | A | Automatic Stock Option Grant | 39072 | $0.00 | 39,072.0000 | 185,908,000 | 9999.99% | 0.02% |
| May 31, 2023 | BIOCRYST PHARMACEUTICALS INC | $BCRX | LEVIN ALAN G | Director | A | Common Stock | 1360 | $8.27 | 20,345.0000 | 185,908,000 | 7.16% | 0.00% |
| Feb. 28, 2023 | BIOCRYST PHARMACEUTICALS INC | $BCRX | LEVIN ALAN G | Director | A | Common Stock | 1271 | $8.85 | 18,985.0000 | 185,908,000 | 7.18% | 0.00% |